Type of Cancer
Lymphoma
Phase
Division (Location)
Study ID
NCT#
Brief Description
A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) ( 2nd to 6th Line)
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.